Indian J Med Microbiol Close
 

Figure 2: (a-c) The progression-free survival since initiation of third-line therapy according to cases of changing prior treatment: progression disease and toxicity. The progression-free survival since initiation of third-line therapy according to cases of changing prior treatment: progression disease and toxicity. The overall survival since the initiation of third-line therapy

Figure 2: (a-c) The progression-free survival since initiation of third-line therapy according to cases of changing prior treatment: progression disease and toxicity. The progression-free survival since initiation of third-line therapy according to cases of changing prior treatment: progression disease and toxicity. The overall survival since the initiation of third-line therapy